263 related articles for article (PubMed ID: 17581634)
1. The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN.
Papakonstanti EA; Ridley AJ; Vanhaesebroeck B
EMBO J; 2007 Jul; 26(13):3050-61. PubMed ID: 17581634
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages.
Papakonstanti EA; Zwaenepoel O; Bilancio A; Burns E; Nock GE; Houseman B; Shokat K; Ridley AJ; Vanhaesebroeck B
J Cell Sci; 2008 Dec; 121(Pt 24):4124-33. PubMed ID: 19033389
[TBL] [Abstract][Full Text] [Related]
3. Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase.
Eickholt BJ; Ahmed AI; Davies M; Papakonstanti EA; Pearce W; Starkey ML; Bilancio A; Need AC; Smith AJ; Hall SM; Hamers FP; Giese KP; Bradbury EJ; Vanhaesebroeck B
PLoS One; 2007 Sep; 2(9):e869. PubMed ID: 17846664
[TBL] [Abstract][Full Text] [Related]
4. Focal adhesion kinase phosphorylates the phosphatase and tensin homolog deleted on chromosome 10 under the control of p110δ phosphoinositide-3 kinase.
Tzenaki N; Aivaliotis M; Papakonstanti EA
FASEB J; 2015 Dec; 29(12):4840-52. PubMed ID: 26251180
[TBL] [Abstract][Full Text] [Related]
5. RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27.
Hsu YH; Chang CC; Yang NJ; Lee YH; Juan SH
J Cell Physiol; 2014 Oct; 229(10):1455-65. PubMed ID: 24535918
[TBL] [Abstract][Full Text] [Related]
6. The RhoA-ROCK-PTEN pathway as a molecular switch for anchorage dependent cell behavior.
Yang S; Kim HM
Biomaterials; 2012 Apr; 33(10):2902-15. PubMed ID: 22244698
[TBL] [Abstract][Full Text] [Related]
7. Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110δ isoform of PI 3-kinase.
Zwaenepoel O; Tzenaki N; Vergetaki A; Makrigiannakis A; Vanhaesebroeck B; Papakonstanti EA
FASEB J; 2012 Feb; 26(2):691-706. PubMed ID: 22084313
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages.
Goulielmaki E; Bermudez-Brito M; Andreou M; Tzenaki N; Tzardi M; de Bree E; Tsentelierou E; Makrigiannakis A; Papakonstanti EA
Cell Death Dis; 2018 Jun; 9(6):678. PubMed ID: 29880805
[TBL] [Abstract][Full Text] [Related]
9. The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilin.
Zheng Y; Ouyang Q; Fu R; Liu L; Zhang H; Hu X; Liu Y; Chen Y; Gao N
Cell Death Dis; 2018 May; 9(6):656. PubMed ID: 29844397
[TBL] [Abstract][Full Text] [Related]
10. High levels of p110δ PI3K expression in solid tumor cells suppress PTEN activity, generating cellular sensitivity to p110δ inhibitors through PTEN activation.
Tzenaki N; Andreou M; Stratigi K; Vergetaki A; Makrigiannakis A; Vanhaesebroeck B; Papakonstanti EA
FASEB J; 2012 Jun; 26(6):2498-508. PubMed ID: 22391131
[TBL] [Abstract][Full Text] [Related]
11. RhoA/ROCK/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo.
Li G; Liu L; Shan C; Cheng Q; Budhraja A; Zhou T; Cui H; Gao N
Cell Death Dis; 2014 Jan; 5(1):e998. PubMed ID: 24434521
[TBL] [Abstract][Full Text] [Related]
12. The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells.
Janas ML; Hodson D; Stamataki Z; Hill S; Welch K; Gambardella L; Trotman LC; Pandolfi PP; Vigorito E; Turner M
J Immunol; 2008 Jan; 180(2):739-46. PubMed ID: 18178811
[TBL] [Abstract][Full Text] [Related]
13. Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor.
Berenjeno IM; Guillermet-Guibert J; Pearce W; Gray A; Fleming S; Vanhaesebroeck B
Biochem J; 2012 Feb; 442(1):151-9. PubMed ID: 22150431
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
[TBL] [Abstract][Full Text] [Related]
15. The PI3K/Akt signaling pathway exerts effects on the implantation of mouse embryos by regulating the expression of RhoA.
Liu L; Wang Y; Yu Q
Int J Mol Med; 2014 May; 33(5):1089-96. PubMed ID: 24638941
[TBL] [Abstract][Full Text] [Related]
16. The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner.
Charette ST; McCance DJ
Oncogene; 2007 Nov; 26(52):7386-90. PubMed ID: 17533372
[TBL] [Abstract][Full Text] [Related]
17. Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits.
Jiang X; Chen S; Asara JM; Balk SP
J Biol Chem; 2010 May; 285(20):14980-14989. PubMed ID: 20231295
[TBL] [Abstract][Full Text] [Related]
18. Distinctive and selective route of PI3K/PKCα-PKCδ/RhoA-Rac1 signaling in osteoclastic cell migration.
Kim JM; Kim MY; Lee K; Jeong D
Mol Cell Endocrinol; 2016 Dec; 437():261-267. PubMed ID: 27576187
[TBL] [Abstract][Full Text] [Related]
19. PI 3-kinase and cancer: changing accents.
Vogt PK; Gymnopoulos M; Hart JR
Curr Opin Genet Dev; 2009 Feb; 19(1):12-7. PubMed ID: 19185485
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of PI3K p110δ inhibits CSF-1-induced macrophage spreading and invasive capacity.
Mouchemore KA; Sampaio NG; Murrey MW; Stanley ER; Lannutti BJ; Pixley FJ
FEBS J; 2013 Nov; 280(21):5228-36. PubMed ID: 23648053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
